Tiantan Biotech: Tiantan Biotech Director\'s Resignation Notice
Tiantan Biotech Director\'s Resignation Notice
Tiantan Biotech\'s announcement on its companies obtaining clinical trial summary reports
Tiantan Biotech\'s announcement on the progress of drug clinical trials of affiliated companies
Tiantan Biotech\'s announcement that its company has obtained an approval notice for clinical trials with new indications
Announcement of Resignation of Director and General Manager of Beijing Tiantan Biological Products Corporation.
Announcement on Completing Industrial and Commercial Registration Change and Issuing a New Business License by Beijing Tiantan Biological Products Corporation.
Announcement of Resolutions of Tiantan Biotech's 2023 Annual General Meeting of Shareholders
Legal Opinion of Beijing Jiayuan Law Firm on the 2023 Annual General Meeting of Shareholders of Beijing Tiantan Biological Products Co., Ltd.
Tiantan Biotech 2023 Annual General Meeting of Shareholders Meeting Documents
Tiantan Biotech's announcement on the progress of drug clinical trials of affiliated companies
Tiantan Biotech Announces Holding the 2023 Annual Results and Cash Dividend Briefing
Notice of Tiantan Biotech on convening the 2023 Annual General Meeting of Shareholders
Tiantan Biotech 2023 Internal Control Evaluation Report
Tiantan Biotech Board Audit and Risk Management Committee 2023 Performance Report
Report by the Audit and Risk Management Committee of the Board of Directors of Tiantan Biotech on the implementation of supervisory duties by accounting firms in 2023
Tiantan Biotech Board of Directors Rules of Procedure
Tiantan Biotech Board Audit and Risk Management Committee Implementation Rules
Tiantan Biotech Board Performance Evaluation and Remuneration Committee Implementation Rules
Tiantan Biotech Board Strategy and Investment Committee Implementation Rules
No Data